Chen Shu-Chih 4
4 · ATOSSA THERAPEUTICS, INC. · Filed May 16, 2025
Insider Transaction Report
Form 4
Chen Shu-Chih
DirectorChief Scientific Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2025-05-15+125,000→ 125,000 totalExercise: $0.99Exp: 2035-05-15→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The options shall vest on a quarterly basis over 12 months following May 15, 2025, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued on May 15, 2025 with an exercise price of $0.99, representing the closing stock price on May 15, 2025.